Charme and Miura launch the sale process of Indiba valued at 500 million
Evercore is coordinating the sale of the company known for its radiofrequency treatments, which is stirring the appetite of funds.
Charme Capital Partners and Miura Partners have launched the sale of Indiba, a Spanish company that provides radiofrequency treatments for aesthetics, beauty, rehabilitation, sports, and intimate health. The sale process, coordinated by Evercore, aims to be completed by the end of the year, with a potential valuation of around 500 million euros.
Indiba's annual revenues exceed 100 million euros, with around half coming from Asia, and its EBITDA is expected to reach around 40 million euros by the end of the year. The company's shareholders, including Charme, Miura, and Tresmares, acquired Indiba from Magnum Capital in 2022 and have since more than doubled its size.
Written by urgent.news from Expansion ES's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
